HBP News and Press, Huttig Building Products Inc. From 02/14/20

ST. LOUIS, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its fourth quarter 2019...

RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced tha...

RICHMOND HILL, Ontario, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it ...

RICHMOND HILL, Ontario, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it ...

RICHMOND HILL, Ontario, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the first quarter of fiscal 2020 end...

RICHMOND HILL, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the sta...

Huttig Building Products, Inc. (HBP) Q3 2019 Earnings Conference Call October 29, 2019 11:00 AM ET Company Participants Philip Keipp – Vice President and Chief Financial Officer Jon Vrabely – President and Chief Executive Officer Bob Furio – Executive Vice Pr...

Huttig Building Products (NASDAQ: HBP ): Q3 GAAP EPS of $0.06. Revenue of $215.7M (-2.8% Y/Y) Press Release More news on: Huttig Building Products, Inc., Earnings news and commentary, ,

Third Quarter 2019 Highlights: Net sales of $215.7 million Gross margin increased to 20.7% Cash provided by continuing operations of $9.6 million Debt reduced nearly $15 million from prior year; total liquidity increased over $9 million ST. LOUIS, Oct. 28, 2019 (GLOBE ...

RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2019. FINANCIAL...